At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 70 enrolled
Drug / intervention
ChiNing decoctiondrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized,Controlled Clinical Trial on the Efficacy and Safety of Chining Decoction in the Treatment of Radiation Stomatitis.
Tianjin Medical University Cancer Institute and Hospital·interventional·Posted Nov 27, 2014·Updated Dec 22, 2015
In Brief
A Phase 3 clinical trial evaluating ChiNing decoction for Head and Neck Cancer. Completed, enrolled 70 participants across 1 site.
Detailed Summary
This study evaluates the efficiency and safety of ChiNing decoction to head and neck cancer patients with radioactive stomatitis. Half of participants will receive ChiNing decoction, while others will receive recombinant human epidermal growth factor (rhEGF) spray.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHead and Neck Cancer
CountriesChina
Collaborators--
Timeline
Phase 3CompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartMay 2014
First PostedNov 2014
Primary CompletionDec 2015
TodayJul 2026
First PostedNov 27, 2014
Enrollment StartMay 1, 2014
Primary CompletionDec 1, 2015
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 11.6 years ago
Interventions
ChiNing decoctiondrug
ChiNing decotion was reformed by Liangge San that was stemed from Prescriptions of the Bureau of Taiping People.